Our scientific team can develop assays to characterize your cell-based therapy in order to assess its suitability early in the development process, minimizing downstream risk. Characterization services include:
Our scientific team can develop release assays to ensure the safety, identity, purity, potency, and dose determination of your cell-based therapeutic product. Release testing services include:
Kincell Bio facilities are well equipped with a range of platform technologies, enabling us to provide comprehensive analytical solutions. Our analytical platform includes:
A dedicated Project Manager ensures your development program stays on track, at every step. Careful planning up-front is focused on defining a tailored control strategy and release testing paradigm, matching your program needs with available technologies to solve for key elements of the target product profile.
Throughout the analytical development process, we keep you informed with responsive communication.
Featured news
Kincell Bio Inc., a cell therapy contract development and manufacturing organization, today announced the signing of a memorandum of understanding with the Duke University School.
1622 NW 55th Place
Gainesville, FL 32653
20 TW Alexander Dr, Suite 130
RTP, NC 27713
“Our scientists often have novel ideas and different ways of approaching problems, which excites us, as well as current and potential clients.”
“We stay at the cutting edge, especially in a field that’s rapidly evolving, so we’re always able to set our clients up for success.”